Category: Trading Advice

Shares of the Tellurian Inc. (TELL) stock rallied in the intraday trading today on September 27, 2021. TELL stock price saw a push of 6.37% to reach $3.92 a share as of this writing. The trading volume as of now was nearly six million. Tellurian Inc is a natural gas production company that runs the natural gas business across the globe. It has 72 producing wells and owns interests in 9,373 net acres of natural gas production assets. It was founded in 2016 and its headquarters are in Houston, Texas. What’s Happening? There is an announcement by the Tellurian stock

Red Cat Holdings, Inc. (RCAT) stock soared today after it announced that its subsidiary Skypersonic received a NASA contract. RCAT stock price saw a surge of 52.50% to reach $3.66 a share as of this writing. The stock also performed well in the previous trade and went up by 7.14% at closing. Red Cat Holdings, Inc along with its subsidiary is the provider of hardware-enabled software products and solutions to the drone industry. It also develops and sells various kinds of drones through its eCommerce platform, www.rotorriot.com. Let’s discuss recent events of this stock. What’s Happening? Red Cat stock today

Sunlands Technology Group (STG) stock prices were down by 1.02% as of the market closing on September 24th, 2021. This brought the price per share down to USD$5.83 at the end of the trading day. Subsequent aftermarket fluctuations have seen the stock fall by 5.66%, bringing it down to USD$5.50. STG Stock’s Non-Compliance August 20th, 2021 saw STG stock announce having received a letter from the NYSE in regard to its noncompliance with ADS Trading Price regulations. The letter was dated July 23rd, 2021 and resulted from the company’s trading price for its ADSs falling below required levels. The company

Aspen Group, Inc. (ASPU) has seen an incline of 6.48% in the aftermarket. However, the last trading session concluded at $5.09 with a decrease of 1.17%. ASPU Records Revenue of $19.4 million Growth in First Quarter Fiscal 2022 ASPU announced on 17th September 2021 that the company has observed $19.4% growth in the first quarter of fiscal 2022. From $15.2 million in Fiscal Q1 2021 to $19.4 million in Fiscal Q1 2022, revenue rose by 28 percent. The BSN Pre-Licensure program at Aspen University (AU) contributed for 23% of overall Company income, with United States University (USU) accounting for 32%.

NLS Pharmaceutics AG (NLSP) has experienced an increase of 2.32% in the aftermarket. However, the last trading session closed at $2.59 with an incline of 1.97%. NLSP to participate in Benzinga Healthcare Small-Cap Conference NLSP announced on 24th September 2021 that Alex Zwyer, the company’s Chief Executive Officer and Co-Founder, will take part in a live interview. Also, they will meet with investors at the Benzinga Healthcare Small-Cap Conference, which will be placed digitally on September 29-30, 2021. Phase 2 Trial for Quilience in Narcolepsy NLSP stated Phase 2 Trial for Quilience in Narcolepsy on 14th September 2021. Quiliencease, a

Trinity Biotech plc (TRIB) stock has experienced an increase of 10.09% in the aftermarket. However, the last trading session closed at $2.18 with a decline of 6.44%. Second Quarter 2021 Financial Results TRIB announced second-quarter 2021 financial results on 9th September 2021. When comparing Q2 2020 to Q2, 2021, point-of-care revenues grew by approximately 55 percent, from $1.3 million to $2.0 million. Higher HIV income from Africa-related sales contributed to the rise. COVID-19-related logistical restrictions have a substantial impact on sales in Q2 2020. While some of these restrictions have lessened, COVID-19 continues to wreak havoc on HIV testing in

Shares of the ZIVO Bioscience, Inc. (ZIVO) stock soared in the intraday trading today on September 24, 2021. ZIVO stock price saw a surge of 62.32% to reach $5.60 a share at the time of this writing. The trading volume as of now was 51,312,776, far higher than the average trading volume. Let’s understand the reason behind this rally What’s Happening? There is no recent announcement or press release by the ZIVO Bioscience in today’s date or not even in the previous week.  Sometimes analysts’ upgrades add hype to the per-share price of the stock but this is not the

Capricor Therapeutics, Inc. (CAPR) stock popped high today after it announced positive final data from its Phase 2 HOPE-2 Trial. CAPR stock price saw a push of 16.53% to reach $5.85 a share as of this writing. The stock went up in the previous trade by 3.29% at closing. Capricor Therapeutics, Inc is the biotech stock that develops transformative cell- and exosome-based therapeutics to treat broad-spectrum diseases. Its lead product candidate is CAP-1002 which has now completed phase 2 trial to treat patients with late-stage Duchenne muscular dystrophy. Let’s dig in to explore more of it. What’s Happening? Capricor therapeutics

Progress Software Corp. (PRGS) stock prices were up by 2.21% as of the market closing on September 23rd, 2021. This brought the price per share up to USD$46.21 at the end of the trading day. Subsequent premarket fluctuations have seen the stock rise by 8.16%, bringing it up to USD$49.98. PRGS Stock Raises Guidance PRGS stock reported third-quarter fiscal 2021 results that substantially exceeded the company’s previous guidance for revenue and earnings. Accordingly, the company is raising its guidance for the 2021 year for the third time. Further consolidating this promising progress was the signing of a definitive agreement to

Aehr Test Systems (AEHR) stock prices were down by 1.01% as of the market closing on September 23rd 2021. This brought the price per share down to USD$11.78 at the end of the trading day. Subsequent premarket fluctuations have seen the stock rise by 23.17%, bringing it up to USD$2.73. AEHR Stock’s Stellar Financials AEHR stock reported net sales for the first quarter of fiscal 2022 in the amount of USD$5.6 million. This is a 181% increase from the USD$2 million in the first quarter of fiscal 2021. GAAP net income came in at USD$696,000, representing a net income of